Global (United States, European Union and China) Needle-Free Drug Injection Systems Market Research Report 2019-2025

Table of Contents

1 Report Overview

• 1.1 Research Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Needle-Free Drug Injection Systems Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Jet-Based Needle-Free Injectors
  • 1.3.3 Spring-Based Needle-Free Injectors
  • 1.3.4 Laser-Powered Needle-Free Injectors
  • 1.3.5 Vibration-Based Needle-Free Injectors
• 1.4 Market Segment by Application
  • 1.4.1 Global Needle-Free Drug Injection Systems Market Share by Application (2019-2025)
  • 1.4.2 Hospitals and Clinics
  • 1.4.3 Homecare Settings
  • 1.4.4 Research Laboratories
  • 1.4.5 Pharmaceutical and Biotechnology companies
  • 1.4.6 Other End Users
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Production and Capacity Analysis
  • 2.1.1 Global Needle-Free Drug Injection Systems Production Value 2014-2025
  • 2.1.2 Global Needle-Free Drug Injection Systems Production 2014-2025
  • 2.1.3 Global Needle-Free Drug Injection Systems Capacity 2014-2025
  • 2.1.4 Global Needle-Free Drug Injection Systems Marketing Pricing and Trends
• 2.2 Key Producers Growth Rate (CAGR) 2019-2025
  • 2.2.1 Global Needle-Free Drug Injection Systems Market Size CAGR of Key Regions
  • 2.2.2 Global Needle-Free Drug Injection Systems Market Share of Key Regions
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Capacity and Production by Manufacturers
  • 3.1.1 Global Needle-Free Drug Injection Systems Capacity by Manufacturers
  • 3.1.2 Global Needle-Free Drug Injection Systems Production by Manufacturers
• 3.2 Revenue by Manufacturers
  • 3.2.1 Needle-Free Drug Injection Systems Revenue by Manufacturers (2014-2019)
  • 3.2.2 Needle-Free Drug Injection Systems Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Needle-Free Drug Injection Systems Market Concentration Ratio (CR5 and HHI)
• 3.3 Needle-Free Drug Injection Systems Price by Manufacturers
• 3.4 Key Manufacturers Needle-Free Drug Injection Systems Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Needle-Free Drug Injection Systems Market
• 3.6 Key Manufacturers Needle-Free Drug Injection Systems Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Production and Production Value for Each Type
  • 4.1.1 Jet-Based Needle-Free Injectors Production and Production Value (2014-2019)
  • 4.1.2 Spring-Based Needle-Free Injectors Production and Production Value (2014-2019)
  • 4.1.3 Laser-Powered Needle-Free Injectors Production and Production Value (2014-2019)
  • 4.1.4 Vibration-Based Needle-Free Injectors Production and Production Value (2014-2019)
• 4.2 Global Needle-Free Drug Injection Systems Production Market Share by Type
• 4.3 Global Needle-Free Drug Injection Systems Production Value Market Share by Type
• 4.4 Needle-Free Drug Injection Systems Ex-factory Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Needle-Free Drug Injection Systems Consumption by Application

6 Production by Regions

• 6.1 Global Needle-Free Drug Injection Systems Production (History Data) by Regions 2014-2019
• 6.2 Global Needle-Free Drug Injection Systems Production Value (History Data) by Regions
• 6.3 United States
  • 6.3.1 United States Needle-Free Drug Injection Systems Production Growth Rate 2014-2019
  • 6.3.2 United States Needle-Free Drug Injection Systems Production Value Growth Rate 2014-2019
  • 6.3.3 Key Players in United States
  • 6.3.4 United States Needle-Free Drug Injection Systems Import & Export
• 6.4 European Union
  • 6.4.1 European Union Needle-Free Drug Injection Systems Production Growth Rate 2014-2019
  • 6.4.2 European Union Needle-Free Drug Injection Systems Production Value Growth Rate 2014-2019
  • 6.4.3 Key Players in European Union
  • 6.4.4 European Union Needle-Free Drug Injection Systems Import & Export
• 6.5 China
  • 6.5.1 China Needle-Free Drug Injection Systems Production Growth Rate 2014-2019
  • 6.5.2 China Needle-Free Drug Injection Systems Production Value Growth Rate 2014-2019
  • 6.5.3 Key Players in China
  • 6.5.4 China Needle-Free Drug Injection Systems Import & Export
• 6.6 Rest of World
  • 6.6.1 Japan
  • 6.6.2 Korea
  • 6.6.3 India
  • 6.6.4 Southeast Asia

7 Needle-Free Drug Injection Systems Consumption by Regions

• 7.1 Global Needle-Free Drug Injection Systems Consumption (History Data) by Regions
• 7.2 United States
  • 7.2.1 United States Needle-Free Drug Injection Systems Consumption by Type
  • 7.2.2 United States Needle-Free Drug Injection Systems Consumption by Application
• 7.3 European Union
  • 7.3.1 European Union Needle-Free Drug Injection Systems Consumption by Type
  • 7.3.2 European Union Needle-Free Drug Injection Systems Consumption by Application
• 7.4 China
  • 7.4.1 China Needle-Free Drug Injection Systems Consumption by Type
  • 7.4.2 China Needle-Free Drug Injection Systems Consumption by Application
• 7.5 Rest of World
  • 7.5.1 Rest of World Needle-Free Drug Injection Systems Consumption by Type
  • 7.5.2 Rest of World Needle-Free Drug Injection Systems Consumption by Application
  • 7.5.1 Japan
  • 7.5.2 Korea
  • 7.5.3 India
  • 7.5.4 Southeast Asia

8 Company Profiles

• 8.1 Antares Pharma, Inc. (US)
  • 8.1.1 Antares Pharma, Inc. (US) Company Details
  • 8.1.2 Company Description and Business Overview
  • 8.1.3 Production and Revenue of Needle-Free Drug Injection Systems
  • 8.1.4 Needle-Free Drug Injection Systems Product Introduction
  • 8.1.5 Antares Pharma, Inc. (US) Recent Development
• 8.2 Endo International plc (US)
  • 8.2.1 Endo International plc (US) Company Details
  • 8.2.2 Company Description and Business Overview
  • 8.2.3 Production and Revenue of Needle-Free Drug Injection Systems
  • 8.2.4 Needle-Free Drug Injection Systems Product Introduction
  • 8.2.5 Endo International plc (US) Recent Development
• 8.3 PharmaJet (U.S)
  • 8.3.1 PharmaJet (U.S) Company Details
  • 8.3.2 Company Description and Business Overview
  • 8.3.3 Production and Revenue of Needle-Free Drug Injection Systems
  • 8.3.4 Needle-Free Drug Injection Systems Product Introduction
  • 8.3.5 PharmaJet (U.S) Recent Development
• 8.4 Bioject Medical Technologies Inc. (U.S)
  • 8.4.1 Bioject Medical Technologies Inc. (U.S) Company Details
  • 8.4.2 Company Description and Business Overview
  • 8.4.3 Production and Revenue of Needle-Free Drug Injection Systems
  • 8.4.4 Needle-Free Drug Injection Systems Product Introduction
  • 8.4.5 Bioject Medical Technologies Inc. (U.S) Recent Development
• 8.5 Medical International Technology, Inc. (U.S)
  • 8.5.1 Medical International Technology, Inc. (U.S) Company Details
  • 8.5.2 Company Description and Business Overview
  • 8.5.3 Production and Revenue of Needle-Free Drug Injection Systems
  • 8.5.4 Needle-Free Drug Injection Systems Product Introduction
  • 8.5.5 Medical International Technology, Inc. (U.S) Recent Development
• 8.6 INJEX Pharma AG (Germany)
  • 8.6.1 INJEX Pharma AG (Germany) Company Details
  • 8.6.2 Company Description and Business Overview
  • 8.6.3 Production and Revenue of Needle-Free Drug Injection Systems
  • 8.6.4 Needle-Free Drug Injection Systems Product Introduction
  • 8.6.5 INJEX Pharma AG (Germany) Recent Development
• 8.7 National Medical Products Inc. (US)
  • 8.7.1 National Medical Products Inc. (US) Company Details
  • 8.7.2 Company Description and Business Overview
  • 8.7.3 Production and Revenue of Needle-Free Drug Injection Systems
  • 8.7.4 Needle-Free Drug Injection Systems Product Introduction
  • 8.7.5 National Medical Products Inc. (US) Recent Development
• 8.8 Valeritas, Inc. (US)
  • 8.8.1 Valeritas, Inc. (US) Company Details
  • 8.8.2 Company Description and Business Overview
  • 8.8.3 Production and Revenue of Needle-Free Drug Injection Systems
  • 8.8.4 Needle-Free Drug Injection Systems Product Introduction
  • 8.8.5 Valeritas, Inc. (US) Recent Development
• 8.9 European Pharma Group (Netherland)
  • 8.9.1 European Pharma Group (Netherland) Company Details
  • 8.9.2 Company Description and Business Overview
  • 8.9.3 Production and Revenue of Needle-Free Drug Injection Systems
  • 8.9.4 Needle-Free Drug Injection Systems Product Introduction
  • 8.9.5 European Pharma Group (Netherland) Recent Development
• 8.10 PenJet Corporation (U.S)
  • 8.10.1 PenJet Corporation (U.S) Company Details
  • 8.10.2 Company Description and Business Overview
  • 8.10.3 Production and Revenue of Needle-Free Drug Injection Systems
  • 8.10.4 Needle-Free Drug Injection Systems Product Introduction
  • 8.10.5 PenJet Corporation (U.S) Recent Development
• 8.11 Crossject SA (France)

9 Market Forecast

• 9.1 Global Market Size Forecast
  • 9.1.1 Global Needle-Free Drug Injection Systems Capacity, Production Forecast 2019-2025
  • 9.1.2 Global Needle-Free Drug Injection Systems Production Value Forecast 2019-2025
• 9.2 Market Forecast by Regions
  • 9.2.1 Global Needle-Free Drug Injection Systems Production and Value Forecast by Regions 2019-2025
  • 9.2.2 Global Needle-Free Drug Injection Systems Consumption Forecast by Regions 2019-2025
• 9.3 United States
  • 9.3.1 Production and Value Forecast in United States
  • 9.3.2 Consumption Forecast in United States
• 9.4 European Union
  • 9.4.1 Production and Value Forecast in European Union
  • 9.4.2 Consumption Forecast in European Union
• 9.5 China
  • 9.5.1 Production and Value Forecast in China
  • 9.5.2 Consumption Forecast in China
• 9.6 Rest of World
  • 9.6.1 Japan
  • 9.6.2 Korea
  • 9.6.3 India
  • 9.6.4 Southeast Asia
• 9.7 Forecast by Type
  • 9.7.1 Global Needle-Free Drug Injection Systems Production Forecast by Type
  • 9.7.2 Global Needle-Free Drug Injection Systems Production Value Forecast by Type
• 9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis

• 10.1 Value Chain Analysis
• 10.2 Sales Channels Analysis
  • 10.2.1 Needle-Free Drug Injection Systems Sales Channels
  • 10.2.2 Needle-Free Drug Injection Systems Distributors
• 10.3 Needle-Free Drug Injection Systems Customers

11 Opportunities & Challenges, Threat and Affecting Factors

• 11.1 Market Opportunities
• 11.2 Market Challenges
• 11.3 Porter's Five Forces Analysis

12 Key Findings

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details